Closed tender

BCG Vaccine & TB Skin Test (2027)

Details

Buyer: UK Health Security Agency
Published: 11 May 2026
Submission: 15 June 2026
Source: uk:atamis:dhsc

Tender description

The UK Health Security Agency (UKHSA) wishes to establish contracts for the provision of i) Bacillus Calmette-Guérin (BCG) vaccine and ii) intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection

Timeline

Completed: Tender published11 May 2026
Current notice
Completed: Submission date15 June 2026

About the buyer

The UK Health Security Agency (UKHSA) is an executive agency sponsored by the Department of Health and Social Care, and buys through its own end-to-end commercial service. Procurement, contract management and market engagement sit within the Commercial, Vaccines and Countermeasures Delivery directorate. UKHSA hosts the Diagnostics and Research Open Framework for diagnostics and research supplies and services.

A published pipeline lists larger planned commercial activity.

Over the past 5 years, most of UK Health Security Agency's contract awards have been in medical equipment and pharmaceuticals, laboratory and precision equipment and software and information systems.

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Commercial Director	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Procurement Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Category Lead	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Senior Buyer	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Contracts Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov